p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions
article
OA: bronze
CC0
⤵ 10 in-corpus citations
AI-generated summary
This study analyzed the protein expression of p16, retinoblastoma (pRb), and cyclin D1 in human endometriotic and adenomyotic lesions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo investigate the expression of p16, retinoblastoma (pRb), and cyclin D1 oncoproteins in endometriomas and adenomyosis.DesignImmunohistochemical study for p16, pRb, and cyclin D1 proteins in formalin-fixed paraffin-embedded endometriotic and adenomyotic tissues.SettingUniversity hospital.Patient(s)Tissues from 25 women with endometriomas and 31 women with adenomyosis were evaluated.Intervention(s)Tissue samples were collected during gynecologic surgery and confirmed by histology to have endometriosis or adenomyosis. Nuclear expression of p16, pRb, and cyclin D1 proteins was examined by immunohistochemistry.Main outcome measure(s)Distribution and intensity of immunostaining.Result(s)In the proliferative phase of the cycle, p16 was detected in 77% of adenomyosis tissues but in only 15% of endometriosis tissues. Moreover, in adenomyosis samples positive for p16, 100% of the adenomyotic cells expressed p16, whereas only 10%-20% of endometriosis cells from positive cases expressed p16. In contrast, pRb was detected in 28% of endometriosis cases but not in any adenomyotic tissues. Cyclin D1 was absent in both endometriotic and adenomyotic tissue samples.Conclusion(s)Differences in oncoprotein expression between endometriotic and adenomyotic tissues provide further evidence that the pathogenesis of endometriosis is different from that of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Adenomyosis via openalex
- Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis via openalex
- Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium via openalex
- Endometriosis and the neoplastic process via openalex
- Pathophysiology of adenomyosis via openalex
- W2003386598 via openalex
- W2007255413 via openalex
- W2010493387 via openalex
- W2025604216 via openalex
- W2046528914 via openalex
- W2066848701 via openalex
- W1503393361 via openalex
- W2078430659 via openalex
- W2080558583 via openalex
- W2084286096 via openalex
- W2100894466 via openalex
- W2130198345 via openalex
- W2301787246 via openalex
- W2477008945 via openalex
- W2067636502 via openalex
- W1576770999 via openalex
- W1972221279 via openalex
- W1999330214 via openalex
- W2002781770 via openalex
Cited by (11)
- p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis 2026
- Idiopathic Abdominal Wall Endometrioma: Case Report with Investigation of the Pathological, Molecular Cytogenetic and Cell Growth Features In Vitro 2025
- Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells 2019
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- Current facts constituting an understandingof the nature of adenomyosis 2018
- Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis 2017
- Les cancers de l’ovaire associés à l’endométriose : physiopathologie et conséquences sur la pratique clinique 2013
- The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis 2012
- Análise da expressão diferencial dos genes ID2, PRELP e SMOC2 em endométrio ectópico e eutópico de mulheres com e sem endometriose na fase proliferativa do ciclo menstrual 2011
- Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis 2010
- A pilot study on the off-label use of valproic acid to treat adenomyosis 2007
Source provenance
- europepmc
- last seen: 2026-09-21T06:08:07.822426+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0
· commercial use OK